Suppr超能文献

Clinical features and infection risks of Chinese children with different types of Gaucher disease.

作者信息

Gan Chuan, Wu Yuanyuan, Qin Tao

机构信息

Department of Infectious Diseases Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, The First Batch of Key Disciplines on Public Health in Chongqing, Chongqing, China.

Health Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.

出版信息

Front Pediatr. 2025 Sep 5;13:1595394. doi: 10.3389/fped.2025.1595394. eCollection 2025.

Abstract

BACKGROUND

Gaucher disease (GD) is a rare autosomal recessive disorder caused by mutations in the glucocerebrosidase1 () gene. Reports on the clinical presentations of various types of GD in Chinese children are scarce, and there is limited research addressing co-occurrence of GD with bacterial (including tuberculosis), viral, or fungal, infections. Pediatric GD typically manifests with greater severity due to developmental vulnerability of organ systems and immature immunity, leading to heightened infection risks. Unlike non-GD children, those with GD exhibit multiorgan involvement (e.g., hepatosplenomegaly, cytopenias) that predisposes them to opportunistic infections. In this study, we describe the clinical features and infection risks associated with different types of GD in Chinese children.

METHODS

This study was done in Children's hospital of Chongqing Medical University. Seventeen patients aged <18 years, diagnosed with GD from January 2008 to December 2019, were enrolled. Clinical symptoms, laboratory results, mutation genotypes, and imaging data were collected for analysis.

RESULTS

Of the 17 patients, 9 were diagnosed with Type 2 GD, while 4 each had Type 1 and 3 GD. Median (interquartile range) age of onset was 7 (3.0-18.5) months. Approximately two-thirds of patients experienced malnutrition, and most exhibited hepatosplenomegaly and hematological abnormalities. Anemia was the most frequent hematological disorder, followed by thrombocytopenia, with almost half developing leukopenia. Liver function abnormalities were common, particularly in Type 2 GD, and characterized by elevated aspartate aminotransferase and glutamyl transpeptidase levels, prolonged prothrombin time, and decreased albumin. Patients with Type 2 GD had increased susceptibility to infections, with respiratory failure from severe infections a leading cause of death. Genome sequencing revealed a novel deletion mutation (c.787_c.788 delAA) in the gene associated with Type 2 GD.

CONCLUSION

In pediatric patients with Gaucher disease, Type 1 GD is associated with worse hematological impairment, while Type 2 GD involves significant hepatic insufficiency and heightened susceptibility to infections.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/12446262/075f43622744/fped-13-1595394-g001.jpg

相似文献

1
Clinical features and infection risks of Chinese children with different types of Gaucher disease.
Front Pediatr. 2025 Sep 5;13:1595394. doi: 10.3389/fped.2025.1595394. eCollection 2025.
5
Enzyme replacement and substrate reduction therapy for Gaucher disease.
Cochrane Database Syst Rev. 2015 Mar 27;2015(3):CD010324. doi: 10.1002/14651858.CD010324.pub2.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.
Ann Hematol. 2024 May;103(5):1765-1774. doi: 10.1007/s00277-024-05710-2. Epub 2024 Mar 20.
9
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Old disease-New reflections: Gaucher, immunity, and inflammation.
J Cell Mol Med. 2024 Oct;28(20):e70087. doi: 10.1111/jcmm.70087.
2
Gaucher Disease for Hematologists.
Turk J Haematol. 2022 Jun 1;39(2):136-139. doi: 10.4274/tjh.galenos.2021.2021.0683. Epub 2022 Apr 20.
3
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Mol Genet Metab. 2022 May;136(1):4-21. doi: 10.1016/j.ymgme.2022.03.001. Epub 2022 Mar 9.
4
Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease.
Sci Rep. 2022 Mar 23;12(1):4977. doi: 10.1038/s41598-022-08843-4.
5
Economic burden and health related quality of life of ultra-rare Gaucher disease in China.
Orphanet J Rare Dis. 2021 Aug 11;16(1):358. doi: 10.1186/s13023-021-01963-6.
6
Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease.
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3535-3542. doi: 10.1016/j.jaip.2020.06.065. Epub 2020 Jul 21.
7
Liver involvement in patients with Gaucher disease types I and III.
Mol Genet Metab Rep. 2020 Jan 7;22:100564. doi: 10.1016/j.ymgmr.2019.100564. eCollection 2020 Mar.
8
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease.
Curr Opin Chem Biol. 2019 Dec;53:204-215. doi: 10.1016/j.cbpa.2019.10.006. Epub 2019 Nov 26.
9
Mutations, modifiers and epigenetics in Gaucher disease: Blurred boundaries between simple and complex disorders.
Mol Genet Metab. 2019 Sep-Oct;128(1-2):10-13. doi: 10.1016/j.ymgme.2019.08.006. Epub 2019 Aug 20.
10
Hyperimmunoglobulinemia and IgG Subclass Abnormalities in Children With Gaucher Disease.
J Pediatr Hematol Oncol. 2019 Oct;41(7):e416-e420. doi: 10.1097/MPH.0000000000001574.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验